-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Cipla?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
90 News & Informationen zur Cipla Aktie
Stock market update: Nifty Pharma index falls 1.3%
The Nifty Pharma index closed 1.3 per cent down at 14479.2.
Sensex, Nifty Edge Higher To Scale New Record Highs
The equity markets are cheering positive macro data points both on global and on the domestic front which is giving confidence to the investors of economic rebound, say experts , , stockmarket, sensex
Cipla Q1 PAT may dip 7.5% YoY to Rs 534.3 cr: ICICI Direct
Net Sales are expected to increase by 11 percent Y-o-Y (up 4.7 percent Q-o-Q) to Rs 4,822.4 crore, according to ICICI Direct.
Antiviral drug Molnupirvir helps mild COVID-19 patients recover faster: Hetero
Earlier, SARS CoV-2 RT-PCR negativity observed in Molnupiravir group compared standard of care at Day 5 was 77.35 percent vs 26.07 percent.
Sensex, Nifty End At Record Highs Led By Gains In Metal Stocks
Buying was visible across the board as all the 11 sector gauges, barring the index of media shares, ended higher led by Nifty Metal index's 2.4% gain.
Sensex Rises Over 100 Points, Nifty Near 15,850 Led By HDFC, HDFC Bank
HDFC, HDFC Bank, Asian Paints, Infosys and Tata Consultancy Services were among the top movers in the Sensex.
Drug firms seek free export of Remdesivir as weak demand inflates inventories
Drug makers had ramped up their capacity to make Remdesivir amid acute scarcity during the second wave of the coronavirus pandemic, but demand has crashed in step with the steep fall in the number of new cases.
Sensex gains in early trade, Nifty nears 15,850; Force Motors climbs 5%, Bajaj Hind 4%
ONGC was the top Nifty50 gainer in early deals, up 3 per cent. Tata Motors, JSW Steel, HDFC Bank and UltraTech Cement were among other blue-chip top performers.
Equity benchmark indices trade higher amid favourable global cues
Read more about Equity benchmark indices trade higher amid favourable global cues on Business Standard. Equity benchmark indices traded over half a per cent higher during early hours on Monday amid favourable global cues.At 10:15 am, the BSE S & P Sensex was up by 296 points or 0.56 per cent at 52,781 and the Nifty 50 ticked higher by 82 points or
Top Pharma Mutual Funds To Start SIP In India 2021 For Long Term Capital Appreciation
As of 2021, the market of pharma industry as per the Indian Economy Survey is estimated at US$ 42 billion in 2021 and expected to scale to US$65 billion by 2024 and further scale to US$120-130 billion by 2030.Amid all such endeavours and the recent aggressiveness the sector is witnessing due to Covid 19 vaccine push etc., it will not be wrong to bet on Indian pharma growth story.
Markets trade flat; pharma stocks gain
With struggling to get momentum, indices are set for over 1 per cent weekly loss.
Sensex, Nifty End Lower For 4th Straight Day
(RTTNews) – Indian shares ended weak on Thursday, weighed down by worries about the surge in the delta variant of the coronavirus cases across the…
Supreme Court sets aside Indoco’s request to lift injunction on launch of generic apixaban
Apex court dismisses Indoco’s petition to lift the stay on producing copycat versions of Bristol Myers Squibb’s bestselling anticoagulant medication
Market Wrap Podcast, June 30: Here's all that happened in the markets today
Read more about Market Wrap Podcast, June 30: Here's all that happened in the markets today on Business Standard. BSE Sensex cooled off 393 points from day's high to end at 52,483 levels, down 67 points or 0.13 per cent. The Nifty50 also eased 27 points, or 0.17 per cent, to settle at 15,721 level
Taking Stock: Market end lower for 3rd straight session; smallcaps outperform
More than 450 stocks, including Zee Media Corporation, Sasken Technologies, SRF and Marico, hit a fresh 52-week high on the BSE.
Cipla records fresh highs on nod for Moderna’s Covid-19 vaccine
Cipla was trading at ₹975.25 on the BSE, down ₹3.80 or 0.39 per cent
Cipla Hits Record High On Pact To Import Moderna's Covid Vaccine
Cipla shares have so far this year surged 22 per cent compared with 10 per cent gain in the Sensex.
Sensex, Nifty Firmly In Positive Territory After Steady Start
(RTTNews) – The Indian stock market is up firmly in positive territory Wednesday morning, led by gains in information technology, automobile and m…
Cipla hits new high on DCGI nod to import Moderna vaccine; up 4% in 2 days
Read more about Cipla hits new high on DCGI nod to import Moderna vaccine; up 4% in 2 days on Business Standard. At this stage, there is no definitive agreement on commercial supplies, the company said in response to media queries on vaccine import
Indian shares gain on auto, tech boost; Cipla rises
Indian shares rose on Wednesday, helped by automakers and information technology stocks, while drugmaker Cipla climbed after getting a regulatory nod to import partner Moderna's COVID-19 vaccine….
Indian shares gain on auto, tech boost; Cipla rises
BENGALURU — Indian shares rose on Wednesday, helped by automakers and information technology stocks, while drugmaker Cipla climbed after getting a regulatory…
Stocks To Watch: Reliance Industries, IRCTC, Cipla
Reliance Industries has signed a pact with Abu Dhabi National Oil Company to jointly build a petrochemicals facility in Ruwais, Abu Dhabi
Indian Shares Likely To Open Higher
(RTTNews) – Higher SGX Nifty and gains in most of the markets in Asia indicate a positive start for Indian shares Wednesday morning. However, un…
Stocks in the news: HDFC, Ruchi Soya, GIC, Ircon and IRCTC
Ircon, Swan Energy, Dish TV India, BF Utilities, Prime Focus, Anant Raj, Andhra Sugars and Sadbhav Engineering will announce their March quarter results today.
Supporting Moderna for Covid vax to be donated to India: Cipla
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik V.
Five pharma majors to conduct clinical trials for Molnupiravir
Trials expected to take place between June and September on 1,200 patients
5 pharma majors collaborate for clinical trial of Molnupiravir for covid-19
The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
Market Wrap Podcast, June 29: Here's all that happened in the markets today
Read more about Market Wrap Podcast, June 29: Here's all that happened in the markets today on Business Standard. BSE Sensex ended the day at 52,549 levels, down 186 points or 0.35 per cent while the broader 50-share Nifty closed at 15,748 levels, down 66 points
Sun Pharma, Cipla and others partner to conduct trials of COVID-19 antiviral drug Molnupiravir
As per the directive of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization, Dr.Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr. Reddy’s in its clinical trial.
Taking Stock: Nifty ends lower for 2nd straight day amid profit-booking; metal, bank stocks underperform
BSE Midcap ended 0.4 percent lower, while Smallcap index ended flat.
Sensex Drops 186 Points; Nifty Ends Below 15,750
(RTTNews) – Indian shares ended lower for a second straight session on Tuesday, with banks, metals and automakers pacing the decliners amid concer…
Sensex extends losses to second day as bank, metal shares weigh on D-Street
Benchmark indices closed in the red amid selling pressure seen in metal and bank stocks.
Sensex, Nifty Decline For Second Straight Session Dragged By Banks
Nine of 11 sector gauges compiled by the National Stock Exchange ended lower led by the Nifty PSU Bank index's 1.5 per cent fall.
Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
The firm submitted its application to the drugs regulator on June 28, CNBC TV-18 has reported.
Bajaj Healthcare requests Indian patent office to grant compulsory licence for COVID-19 drug
The firm approached the Indian Patent Office after Eli Lilly & Company on two occasions declined to sign the voluntary licence for manufacturing and supply of COVID-19 drug Baricitinib
Sensex continues to rise after a day's pause; RIL down 2%
Volatility indicators eased as F&O contracts for the month of June expired, but analysts expect the market to be volatile as valuation concerns are mounting.
Exclusive: KKR-controlled drug maker JBCPL evaluating acquistion of select brands, mid-sized firm
KKR's deep pockets and expertise is expected to help JBCPL to expand quickly using both organic and inorganic options. KKR bought a controlling stake in the Mumbai-based family-owned drug maker JBCPL a year ago for Rs 3,100 crore.
Cipla Receives Final Approval For Generic Version Of Sunovion Pharmaceuticals, Inc.'s Brovana® (Arformoterol Tartrate Inhalation Solution 15 Mcg/ 2mL)
MUMBAI, India, June 23, 2021 /PRNewswire/ — Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as “Cipla”) today announced that it has
Sensex retreats 600 points from day's high, Nifty ends below 15,700; PNB rises 2%
Global cues were positive after the Fed Reserve chairman cleared air on rate hike talks and said the central bank will continue to support the economy and job creation.
Cipla gets USFDA nod for inhalation product
The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing.